Associated Press Report on the First Genetic Manipulation in a Patient's Body

For the first time, scientists have attempted to treat a patient by manipulating genes within their body, resulting in permanent changes. DNA (deoxyribonucleic acid) is a type of nucleic acid that contains genetic information and instructions for the functioning and biological evolution of living organisms. According to an exclusive report by the Associated Press, Brian Maddox, a 44-year-old patient undergoing the first genetic manipulation trial, suffers from 'Hunter syndrome,' which disrupts the patient's metabolism. On Monday of this week, doctors injected billions of gene-editing tools and a genetic instrument for cutting DNA into Mr. Maddox's body. Mr. Maddox stated, 'It’s kind of an honor to be the first person to do this experiment. I’m willing to take this risk and hope this trial helps me and others.' Doctors say it will take a month to see the initial results, and a full three months to observe the complete outcome. A positive result from this trial could strengthen the foundations of the emerging field of gene therapy. Previously, scientists had manipulated individuals' genes outside their bodies—in laboratories—and then returned them to the body. There are also gene therapies that do not necessarily involve DNA manipulation. However, this treatment method is only applicable to a few diseases, and the results of some may not be permanent, with the disease potentially returning after some time. In the trial being conducted on Brian Maddox's body, gene-editing tools are sent into his body like a molecular surgeon. This molecular surgeon knows exactly where to land and which gene to edit. Dr. Sandy Makray, head of Sangamo—a medical company in California researching treatments for two metabolic diseases and hemophilia—stated, 'We cut your DNA. We open it. We insert the gene. We close it again, and it repairs itself invisibly.' This then becomes part of the patient's DNA and will remain in their body for life. However, this means there is no going back, and the altered gene cannot be reversed. Genetic manipulation still faces many critics, especially those who argue that the risks of tampering with nature should never be overlooked. Dr. Eric Topol from the Scripps Translational Science Institute in San Diego remarked, 'You are really playing with nature. The risks of this cannot be determined. But research must continue because there are still many incurable diseases.' According to Dr. Howard Kauffman from the National Institutes of Health, gene therapy has shown very good results in animals. He believes the results from gene therapy are so promising that they cannot be ignored. He stated, 'Now is not the time to be afraid.'